Publications by authors named "Inga Koneczny"

20Publications

Myasthenia Gravis With Antibodies Against Muscle Specific Kinase: An Update on Clinical Features, Pathophysiology and Treatment.

Front Mol Neurosci 2020 2;13:159. Epub 2020 Sep 2.

Nuffield Department of Clinical Neurosciences, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom.

View Article and Find Full Text PDF
September 2020

Update on IgG4-mediated autoimmune diseases: New insights and new family members.

Authors:
Inga Koneczny

Autoimmun Rev 2020 Oct 13;19(10):102646. Epub 2020 Aug 13.

Division of Neuropathology and Neurochemistry, Department of Neurology, Medical University of Vienna, Währingergürtel 18-20, 1090 Vienna, Austria. Electronic address:

View Article and Find Full Text PDF
October 2020

Antibodies to nodal/paranodal proteins in paediatric immune-mediated neuropathy.

Neurol Neuroimmunol Neuroinflamm 2020 07 2;7(4). Epub 2020 Jun 2.

From the Division of Neuropathology and Neurochemistry (D.D.S., G.R., M.W., I.K., R.H.), Department of Neurology, Medical University of Vienna, Austria; Department of Neurology (D.D.S.), University Hospital St. Poelten, Austria; Department of General Pediatrics, Neonatology and Pediatric Cardiology (M.K.), University Children's Hospital, Heinrich Heine University Duesseldorf, Germany; Department of Neuropediatric Rehabilitation (U.H.), Vamed Clinic Hattingen, Germany; Department of Neuropediatrics (U.S.), Charité University, Berlin, Germany; Paediatric Neurology (O.A.-M.), Great Ormond Street Hospital for Children, London, United Kingdom; Dubowitz Neuromuscular Centre (P.M.), Great Ormond Street Hospital for Children, London, United Kingdom; Nuffield Department of Clinical Neurosciences (S.R.), University of Oxford and Oxford University Hospitals NHS Foundation Trust; Department of Paediatric and Adolescent Medicine (C.S.), St Joseph Hospital, Berlin, Germany; Department of Pediatrics and Adolescent Medicine (M.F., M.B., R.S.), Medical University of Vienna, Austria; Department of Neurology (M.R., J.W.), Medical University of Innsbruck, Austria; Neuromuscular Diseases Unit (C.L., L.Q.), Hospital de la Santa Creu i Sant Pau, Universitat Autónoma de Barcelona, Spain; SMZ Süd (G.B.), Kaiser-Franz Josef Hospital with Gottfried von Preyer Children Hospital, Vienna, Austria; Institute of Clinical Chemistry (K.-P.W., R.J., F.L.), University Hospital Schleswig-Holstein, Kiel/Lübeck, Germany; Department of Neurology (F.L.), University Hospital Schleswig-Holstein, Kiel, Germany; and Department of Pediatric Neurology (K.R.), Witten/Herdecke University, Children's Hospital Datteln, Germany.

View Article and Find Full Text PDF
July 2020

Myasthenia gravis AChR antibodies inhibit function of rapsyn-clustered AChRs.

J Neurol Neurosurg Psychiatry 2020 05 12;91(5):526-532. Epub 2020 Mar 12.

Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, Oxfordshire, UK

View Article and Find Full Text PDF
May 2020

Myasthenia Gravis: Pathogenic Effects of Autoantibodies on Neuromuscular Architecture.

Cells 2019 07 2;8(7). Epub 2019 Jul 2.

Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, 1090 Vienna, Austria.

View Article and Find Full Text PDF
July 2019

A New Classification System for IgG4 Autoantibodies.

Authors:
Inga Koneczny

Front Immunol 2018 12;9:97. Epub 2018 Feb 12.

Institute of Neurology, Medical University of Vienna, Vienna, Austria.

View Article and Find Full Text PDF
February 2019

Serological and experimental studies in different forms of myasthenia gravis.

Ann N Y Acad Sci 2018 02 29;1413(1):143-153. Epub 2018 Jan 29.

Neuroimmunology Group, Nuffield Department of Clinical Neurosciences, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK.

View Article and Find Full Text PDF
February 2018

Exploring the effect of vitamin D supplementation on the anti-EBV antibody response in relapsing-remitting multiple sclerosis.

Mult Scler 2018 09 21;24(10):1280-1287. Epub 2017 Jul 21.

School for Mental Health and Neuroscience, Maastricht University Medical Centre, Maastricht, The Netherlands/Academic MS Center Limburg, Zuyderland Medical Center, Sittard, The Netherlands.

View Article and Find Full Text PDF
September 2018

MuSK myasthenia gravis IgG4 disrupts the interaction of LRP4 with MuSK but both IgG4 and IgG1-3 can disperse preformed agrin-independent AChR clusters.

PLoS One 2013 7;8(11):e80695. Epub 2013 Nov 7.

Neurosciences Group, Nuffield Department of Clinical Neurosciences, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom.

View Article and Find Full Text PDF
February 2015

The role of muscle-specific tyrosine kinase (MuSK) and mystery of MuSK myasthenia gravis.

J Anat 2014 Jan 4;224(1):29-35. Epub 2013 Mar 4.

Neurosciences Group, Nuffield Department of Clinical Neurosciences, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.

View Article and Find Full Text PDF
January 2014

The search for new antigenic targets in myasthenia gravis.

Ann N Y Acad Sci 2012 Dec;1275:123-8

Nuffield Department of Clinical Neurosciences, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, United Kingdom.

View Article and Find Full Text PDF
December 2012

Antibodies identified by cell-based assays in myasthenia gravis and associated diseases.

Ann N Y Acad Sci 2012 Dec;1274:92-8

Nuffield Department of Clinical Neurosciences, University of Oxford, John Radcliffe Hospital, United Kingdom.

View Article and Find Full Text PDF
December 2012

Peroxisome-proliferator-activated receptors γ and β/δ mediate vascular endothelial growth factor production in colorectal tumor cells.

J Cancer Res Clin Oncol 2011 Jan 11;137(1):29-39. Epub 2010 Mar 11.

Department of Medicine 1, Clinic for Internal Medicine I, Institute of Cancer Research, Medical University of Vienna, Borschkegasse 8a, 1090 Vienna, Austria.

View Article and Find Full Text PDF
January 2011